Arcadia Biosciences, Inc. (RKDA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.17M | 6.36M | 8.39M | 7.58M | 8.85M | 9.24M | 10.71M | 12.43M | 11.64M | 14.97M | 20.01M | 23.34M |
| Cash & Short-Term Investments | 3.72M | 4.56M | 5.88M | 4.44M | 3.16M | 4.24M | 6.58M | 8.11M | 8.5M | 11.64M | 15.7M | 18.51M |
| Cash Only | 954K | 259K | 1.12M | 1.38M | 3.16M | 4.24M | 3.94M | 5.5M | 3.32M | 6.52M | 10.61M | 13.48M |
| Short-Term Investments | 2.77M | 4.3M | 4.76M | 3.07M | 0 | 0 | 2.64M | 2.6M | 5.18M | 5.12M | 5.09M | 5.02M |
| Accounts Receivable | 425K | 425K | 831K | 1.26M | 3.58M | 1.18M | 2.71M | 2.6M | 760K | 506K | 304K | 630K |
| Days Sales Outstanding | 34.77 | 64.12 | 74.02 | 151.45 | 178.28 | 146.93 | 158.86 | 117.02 | 58.36 | 31.85 | 33.1 | 54.48 |
| Inventory | 840K | 1.21M | 1.46M | 1.49M | 1.28M | 904K | 835K | 978K | 1.83M | 837K | 2.66M | 3.16M |
| Days Inventory Outstanding | 131.91 | 173.16 | 153.3 | 153.18 | 144.44 | 96.73 | 80.81 | 201.91 | 257.74 | 239.89 | 327.34 | 402.85 |
| Other Current Assets | 184K | 156K | 0 | 0 | 823K | 1.99M | 591K | 749K | 550K | 1.99M | 1.34M | 1.04M |
| Total Non-Current Assets | 154K | 190K | 197K | 209K | 4.14M | 4.28M | 4.53M | 4.93M | 4.4M | 4.73M | 3.46M | 3.46M |
| Property, Plant & Equipment | 0 | 8K | 10K | 22K | 47K | 178K | 361K | 567K | 1.02M | 862K | 1.61M | 1.94M |
| Fixed Asset Turnover | - | 100.11x | 81.38x | 42.17x | 10.67x | 4.51x | 3.31x | 1.64x | 1.05x | 0.94x | 0.73x | 0.62x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 39K | 39K | 39K | 39K | 39K | 39K | 39K | 39K | 39K | 39K | 40K | 40K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 3.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 115K | 143K | 148K | 148K | 92K | 4.06M | 4.13M | 4.33M | 3.34M | 3.83M | 1.8M | 1.48M |
| Total Assets | 5.32M | 6.55M | 8.58M | 7.79M | 12.99M | 13.52M | 15.24M | 17.37M | 16.05M | 19.7M | 23.47M | 26.8M |
| Asset Turnover | 0.19x | 0.12x | 0.16x | 0.14x | 0.09x | 0.08x | 0.09x | 0.08x | 0.06x | 0.05x | 0.05x | 0.05x |
| Asset Growth % | -59.02% | -51.57% | -43.68% | -55.16% | -19.05% | -31.4% | -35.05% | -35.19% | -47.23% | -31.87% | -31.93% | -23.45% |
| Total Current Liabilities | 1.36M | 2.06M | 2.29M | 1.84M | 2.22M | 2.56M | 2.33M | 2.7M | 2.88M | 3.59M | 3.88M | 4.09M |
| Accounts Payable | 1.1M | 1.45M | 2.02M | 1.56M | 1.9M | 703K | 1.69M | 1.56M | 1.73M | 485K | 2.6M | 2.78M |
| Days Payables Outstanding | 164.25 | 225 | 185.93 | 190.67 | 171.42 | 133.22 | 144.95 | 236.63 | 214.17 | 211.94 | 302.82 | 389.76 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K |
| Other Current Liabilities | 263K | 606K | 270K | 270K | 270K | 483K | 260K | 495K | 345K | 770K | 313K | 282K |
| Current Ratio | 3.79x | 3.09x | 3.67x | 4.12x | 3.99x | 3.61x | 4.60x | 4.61x | 4.05x | 4.17x | 5.15x | 5.70x |
| Quick Ratio | 3.17x | 2.50x | 3.03x | 3.31x | 3.41x | 3.25x | 4.24x | 4.25x | 3.41x | 3.94x | 4.47x | 4.93x |
| Cash Conversion Cycle | 2.44 | 12.29 | 41.39 | 113.95 | 151.29 | 110.44 | 94.72 | 82.31 | 101.93 | 59.79 | 57.62 | 67.57 |
| Total Non-Current Liabilities | 1.07M | 347K | 856K | 1.42M | 1.87M | 4.73M | 2.76M | 3.1M | 2.69M | 3.41M | 4.18M | 4.98M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11K | 21K | 155K | 347K | 532K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.07M | 347K | 856K | 1.42M | 1.87M | 4.73M | 2.76M | 3.09M | 2.66M | 3.26M | 3.84M | 4.45M |
| Total Liabilities | 2.44M | 2.41M | 3.14M | 3.25M | 4.08M | 7.29M | 5.09M | 5.8M | 5.56M | 7M | 8.07M | 9.07M |
| Total Debt | 0 | 0 | 0 | 11K | 21K | 155K | 346K | 574K | 822K | 1.01M | 1.27M | 1.52M |
| Net Debt | -954K | -259K | -1.12M | -1.36M | -3.14M | -4.09M | -3.59M | -4.93M | -2.5M | -5.51M | -9.34M | -11.96M |
| Debt / Equity | - | - | - | 0.00x | 0.00x | 0.02x | 0.03x | 0.05x | 0.08x | 0.08x | 0.08x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.29x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -2.45x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 2.88M | 4.14M | 5.44M | 4.53M | 8.9M | 6.22M | 10.15M | 11.57M | 10.48M | 12.7M | 15.4M | 17.73M |
| Equity Growth % | -67.6% | -33.47% | -46.37% | -60.81% | -15.05% | -51.01% | -34.09% | -34.77% | -37.2% | -39.22% | -38.45% | -33.76% |
| Book Value per Share | 2.11 | 3.02 | 3.97 | 3.32 | 6.52 | 4.56 | 7.44 | 8.49 | 7.70 | 9.88 | 11.33 | 13.05 |
| Total Shareholders' Equity | 2.88M | 4.14M | 5.44M | 4.53M | 8.9M | 6.22M | 10.29M | 11.7M | 10.62M | 12.84M | 15.54M | 17.87M |
| Common Stock | 66K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K | 65K |
| Retained Earnings | -285.6M | -281.22M | -279.88M | -280.74M | -276.28M | -278.88M | -274.81M | -273.2M | -274.26M | -271.84M | -268.99M | -266.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 117K | 81K | 161K | 101K | 87K | 21K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -138K | -138K | -138K | -138K | -138K | -138K |